Hauptthema · Main Topic
Limitierte und minimal invasive Operationen beim ÖsophaguskarzinomLorenz D. · Origer J. · Graupe F.
Klinik für Allgemein- und Viszeralchirurgie, HSK Dr.-Horst-Schmidt-Kliniken GmbH, Wiesbaden, Deutschland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Limited and Minimally Invasive Operations in Esophageal Cancer Many centers favor a radical esophagectomy combined with systematic lymphadenectomy as standard operation also in early esophageal adenocarcinomas. Because of the substantial morbidity of this procedure the question arises if this surgical intervention is actually necessary in all patients with early carcinomas. The theoretical advantages of minimally invasive resection favor this technique in procedures with high morbidity, particularly as the use of this technique must not be limited to the treatment of early tumor stages. The first large case series are promising though there is a lack of reliable data because randomized controlled trials are still missing and the data from the case series are still controversial. Other strategies to limit the extent of surgical resection in early Barrett’s carcinoma are vagal-sparing esophagectomy and resection of the distal esophagus and esophagogastric junction with regional lymphadenectomy and jejunal interposition (modified Merendino’s technique). However, both procedures are not yet fully developed. In view of the success of endoscopic mucosal resection in esophageal carcinomas limited to the mucosa, we think that there will be no indication for vagal-sparing esophagectomy in the future. In our patients limited resection (Merendino’s technique; n = 29) showed to be advantageous when compared with conventional resection (n = 79) because of substantially lower morbidity and mortality. The patients with limited resection had a significantly shorter stay on the ICU and a shorter length of hospitalization, and the postoperative lost of weight was significantly less in this group as well. The oncologic long-term results in both groups were comparable.
© 2008 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.